Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.55USD
21 Apr 2017
Change (% chg)

$-0.15 (-5.56%)
Prev Close
$2.70
Open
$2.65
Day's High
$2.70
Day's Low
$2.55
Volume
38,039
Avg. Vol
32,493
52-wk High
$4.06
52-wk Low
$2.41

Select another date:

Thu, Apr 6 2017

BRIEF-AcelRx Pharma says DSUVIA resulted in 3-point reduction in pain intensity within 60 minutes of administration

* AcelRx Pharmaceuticals presenting comprehensive DSUVIA clinical trial results at ASRA's annual regional anesthesiology and acute pain medicine meeting

BRIEF-European Medicines Agency begins evaluation of marketing application for sublingual Sufentanil

* European Medicines Agency begins evaluation of marketing application for sublingual Sufentanil 30 mcg tablet (ARX-04) for moderate-to-severe acute pain

BRIEF-Acelrx Pharmaceuticals Q4 loss per share $0.21

* Acelrx Pharmaceuticals reports fourth quarter and year end 2016 financial results

BRIEF-Acelrx says U.S. app to market painkiller Dsuvia accepted by FDA

* Acelrx pharmaceuticals' new drug application for dsuvia accepted for filing with pdufa date of october 12, 2017

BRIEF-Acelrx Pharmaceuticals appoints Vincent Angotti as CEO

* Acelrx Pharmaceuticals appoints Vincent J. Angotti chief executive officer

Select another date:

More From Around the Web